BioSpace News Archive

The Texas Mesothelioma Victims Center says, “We are urging an individual anywhere in Texas with mesothelioma or asbestos exposure lung cancer to call us anytime at 800-714-0303 for our unsurpassed free services.

Freenome, a leading artificial intelligence (AI) genomics company, today announced the appointment of Cheng-Ho Jimmy Lin, MD, PhD, MHS as Chief Scientific Officer (CSO).

Simulations Plus, Inc. (Nasdaq:SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has received an order from the U.S. Food and Drug Administration (FDA) for a 15-user license to its ADMET Predictor® software suite.

Researchers have developed a new method to identify illegally trafficked European eels, and it has already led to the arrest and prosecution of smugglers in Hong Kong.

Evofem Biosciences, Inc., will hold a conference call to discuss financial results and business highlights for the first quarter ended March 31, 2019

New CMS Enrollment Status Strengthens Strategic Partnership with Cambia Health Solutions

Smart pump programming will allow Medfusion® 4000 pumps to be programmed based on the clinician order reducing programming errors

Three renowned neurologists from PIN will join CEO of operational AI data platform to discuss the development of a machine learning model to predict the best treatment therapies for Multiple Sclerosis patients

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, will host a conference call and webcast to report its first quarter 2019 financial results and provide a corporate update on Tuesday, May 7, 2019.

Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is now a member of the Digital Therapeutics Alliance (DTA) (www.DTxAlliance.org).